Becton Dickinson and Co

US

BDX

Health Care

233.88 ₽

Current price

Sell
233.88 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    446 / 663

  • Position in country

    10778 / 14179

  • Return on Assets, %

    2.4

    -11.9

  • Net income margin, %

    5.9

    -12.5

  • EBITDA margin, %

    22.8

    -2.5

  • Debt to Equity, %

    63.5

    15

  • Intangible assets and goodwill, %

    67.3

    3.9

  • Revenue CAGR 3Y, %

    6.4

    12.6

  • Total Equity change 1Y, %

    -0.6

    0

  • Revenue Y, % chg

    4

    4.6

  • P/E

    53.6

    28.3

  • P/BV

    2.6

    1.7

  • P/S

    3.4

    3.7

  • EV/S

    4.2

    3.2

  • EV/EBITDA

    17.4

    -0.2

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    19

    66.5

  • Forward P/E

    17.1

    19.2

  • Dividend Yield, %

    1.6

    1.8

  • Forward Dividend Yield, %

    1.6

    0.2

  • Expected dividend per share

    3.8

    0

  • Payout Ratio, %

    83.9

    17.3

  • Dividend Ex Date

    2024-03-07

Get an analytical review of this company

Competitors

Ranks

  • Dexcom Inc

    00%

  • Boston Scientific Corp

    00%

  • Intuitive Surgical Inc

    00%

  • Stryker Corp

    00%

  • Edwards Lifesciences Corp

    00%

  • IDEXX Laboratories Inc

    00%

  • Abbott Laboratories

    00%

  • GE Healthcare Technologies Inc

    00%

  • Hologic Inc

    00%

  • Becton Dickinson and Co

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    67941.1

  • Ticker

    BDX.N

  • ISIN

    US0758871091

  • IPO date

    1963-09-25

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-01

  • Date fact. publication of reports

    2023-12-31

Company Description

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through segments such as BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including medication delivery solutions, medication management solutions, diabetes care and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products.